Business Context and Reporting Period
This Form 8-K is filed by Helius Medical Technologies, Inc. (not Solana Co) on June 27, 2025. The report details a material modification to the rights of security holders regarding a reverse stock split approved by stockholders on May 23, 2025, and finalized by the Board of Directors on June 20, 2025.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split: A 1-for-50 reverse stock split of Class A Common Stock was approved and filed with the Delaware Secretary of State.
- Effective Date: The split becomes effective at 5:00 p.m. Eastern Time on June 30, 2025.
- Share Count Reduction: Outstanding shares will decrease from approximately 33.8 million to approximately 0.7 million.
- Trading Symbol: The stock will continue to trade on the Nasdaq Capital Market under the symbol "HSDT" with a new CUSIP number (42328V 876).
- Equity Adjustments: Proportionate adjustments will be made to exercise prices and share counts for outstanding options, RSUs, and warrants.
Outlook, Risks, and Management Commentary
The primary objective of the reverse stock split is to enable the Company to comply with the Nasdaq Stock Market's continued listing requirements. Fractional shares resulting from the split will be handled at the Company's election, either by rounding down with cash payment for the fraction or rounding up to the next whole share. The filing references a Definitive Proxy Statement (Schedule 14A) for further details.
Investor Verification Checklist
- Verify the new CUSIP number (42328V 876) for post-split trading on July 1, 2025.
- Confirm the treatment of fractional shares (cash payout vs. rounding up) as determined by the Company.
- Review the impact of the 1-for-50 split on the exercise price and quantity of any held stock options or warrants.
- Monitor the stock price on July 1, 2025, to ensure it reflects the split-adjusted basis.